Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Sep. 30, 2023
Assets
Cash and cash equivalents	$ 24,916,285	$ 9,625,494
Accounts receivable, net	3,960,305	4,506,508
Inventories, net	4,144,179	6,697,117
Prepaid research and development costs	419,371	1,006,252
Prepaid expenses and other current assets	1,783,084	1,097,851
Total current assets	35,223,224	22,933,222
Plant and equipment, net	1,284,654	1,652,732
Operating lease right-of-use asset	3,561,773	4,332,473
Deferred income taxes	12,340,237	12,707,419
Intangible assets, net	0	5,952
Goodwill	6,878,932	6,878,932
Other assets	1,129,952	1,512,361
Total assets	60,418,772	50,023,091
Liabilities and Stockholders' Equity
Accounts payable	3,036,841	12,931,172
Accrued compensation	4,679,696	990,609
Accrued expenses and other current liabilities	2,060,097	1,987,738
Residual royalty agreement, short-term portion (Note 9)	1,025,837	864,623
Operating lease liability, short-term portion	1,065,497	1,036,590
Total current liabilities	11,867,968	17,810,732
Residual royalty agreement, long-term portion (Note 9)	8,850,792	8,870,136
Operating lease liability, long-term portion	2,921,380	3,634,114
Other liabilities	4,461,920	29,948
Total liabilities	28,102,060	30,344,930
Commitments and contingencies (Note 13)
Stockholders' equity:
Preferred stock, no shares issued and outstanding at September 30, 2024 and 2023, respectively	0	0
Common stock, par value $0.01 per share; 308,000,000 shares authorized, 148,567,624 and 93,966,402 shares issued and 146,383,920 and 91,782,698 shares outstanding at September 30, 2024 and 2023, respectively	1,485,676	939,664
Additional paid-in-capital	333,788,795	283,894,830
Accumulated other comprehensive loss	(581,519)	(581,519)
Accumulated deficit	(294,569,635)	(256,768,209)
Treasury stock, 2,183,704 shares, at cost	(7,806,605)	(7,806,605)
Total stockholders' equity	32,316,712	19,678,161
Total liabilities and stockholders' equity	$ 60,418,772	$ 50,023,091